ClinicalTrials.Veeva

Menu

Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System

C

Cepheid

Status

Completed

Conditions

HCV

Treatments

Diagnostic Test: Xpert HCV

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.

Full description

Whole blood specimens were collected from consented individuals with signs and symptoms and/or individuals at-risk of HCV infection, irrespective of HCV antibody status at a single timepoint.

Enrollment

1,012 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant was ≥18 years old
  • Participant was not on treatment at time of enrollment based on review of medical records or self-reported
  • Participant had signs and symptoms and/or is considered at-risk of HCV infection

Exclusion criteria

  • Clinician assessed that the participant was not suitable for inclusion

Trial design

1,012 participants in 1 patient group

Capillary whole blood
Description:
Capillary whole blood from individuals with signs and symptoms and/or at-risk of HCV infection
Treatment:
Diagnostic Test: Xpert HCV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems